"Plasma-first" approach for molecular genotyping in non-small cell lung cancer: A narrative review
{{output}}
Molecular genotyping is essential for management of patients newly diagnosed with advanced non-small cell lung cancer (NSCLC). Plasma circulating tumor DNA (ctDNA) testing has emerged as a complement to tumor tissue genotyping for advanced NSCLC, especially wh... ...
